Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« For Further Enlightenment | Main | Everything's Under Control, Right? »

August 17, 2005

No Such Disease

Email This Entry

Posted by Derek

Are we going to "eliminate the suffering and death due to cancer" by 2015, a goal set by the National Cancer Institute? Unfortunately, I greatly doubt it. Will we speed up the timetable, as Senator Arlen Specter has apparently asked, and do it by 2010? Absolutely not, and here's why.

There's a widespread myth at work here: that there's a disease called cancer. Cancer is actually the end result of what are probably hundreds (thousands?) of different diseases. We have confused ourselves by giving them the same category name - it's like the old-style classification of infections as various "fevers." There are many, many ways that a cell can end up with (and maintain) the deranged growth profile that we think of as cancerous, and it's going to take a lot of different treatments to do anything about them. (See this post and this one for some of the consequences of that for the drug industry.)

Look at the situation today. Every type of tumor has specific front-line treatment regimes, and they don't overlap that much. The best agents for some types of cancer are totally useless against some of the others. It's possible that some of those multikinase inhibitors that I was writing about the other day could have a broader spectrum of activity, but even if that pans out, it's likely that different kinase "fingerprints" will be needed for different varieties of tumor.

Actually, there are two myths at work in Senator Specter's question. The other one is that research can be sped up to any degree desired. Although more money is always nice, thanks, there comes a point where it's not sufficient to buy you better results. In the case of the various cancers, it's for sure that there are many, many important details that we don't even know about yet. And, as usual, a good amount of the things that we do already know are going to turn out to be wrong. Time, money, intelligence, luck, and hard work are all going to have to be tossed into the pot in great quantities, and there are no other ingredients that can substitute for any of those.

Comments (10) + TrackBacks (0) | Category: Cancer


COMMENTS

1. SRC on August 18, 2005 6:07 AM writes...

A common problem in the business world, confusing science with engineering. In the street it takes the form of "If we/they can put a man on the moon..."

Non-scientists fail to differentiate the processes of finding hitherto unknown solutions to poorly understood problems with implementing already known solutions to well-understood problems.

Progress on the latter may be homogeneous to first-order in money spent, but the former is homogeneous to zeroth order. Having more guys stumbling around who don't what to do either isn't a big help when you're trying to figure out what to do next.

Permalink to Comment

2. Peter Ellis on August 18, 2005 6:19 AM writes...

The second myth they're buying into is the one that says that if you start with 40 women, you can get a baby in a week.

Permalink to Comment

3. Groko on August 18, 2005 10:47 AM writes...

Then, on the other hand, angiogenesis as a phenomenon is applicable to all solid cancer tumors...

Permalink to Comment

4. Derek Lowe on August 18, 2005 11:01 AM writes...

Ah, but "angiogenesis as a phenomenon" is driven by a bewildering array of biochemical signals. Not all of them are applicable to a given tumor type, by any means. This is what we're finding out in recent years with the first waves of anti-angiogenic drug candidates, that they don't have nearly the spectrum of activity that we would have hoped for.

Permalink to Comment

5. ctl on August 18, 2005 1:10 PM writes...

I wonder why he set his sights so low. Why not ask for the eradication of all cancers right now? I mean, if you guys in the pharma industry aren't human beings constrained like the rest of us by outside limitations, but creatures who produce your results by sheer willpower, why wait so long for you heartless bastards to get around to wanting to end cancer?

Permalink to Comment

6. jeet on August 18, 2005 2:12 PM writes...

to be kind-of fair, I don't think we had the knowledge thirty years ago when Nixon's "War on Cancer" was launched about the incredible varieties of cancers let alone the knowledge (still incomplete) of various cell control mechanisms that allow us to now look at this disease in a different light.



On the angiogenesis front we have more than direct receptor inhibitors, we also have therapies that use angiogenesis as drug targeting for traditional chemo.



A lot of progress, but not a cure.

Permalink to Comment

7. Dr_Toot on August 18, 2005 5:09 PM writes...

Hey, what's the big deal, it's just a f*cking lawyer talking, since when do we take them seriously. Anyway, politics & its attendant hyperbole will be with us until we're all genetically engineered to actually be nice to each other (shudders). I will say you do a good job explaining the fact that cancer is a variety of diseases; same thing goes for just about everything we stroke our chins & diagnose in medicine: M.S., hyperetension, depression, etc.

Permalink to Comment

8. Utenzi on August 18, 2005 9:48 PM writes...

And don't forget schizophrenia. That's another cluster of ailments under one heading.

Permalink to Comment

9. Ed Reid on August 19, 2005 6:22 PM writes...

If cures for all of the specific diseases typically referred to as cancers were to become available at cob today, the FDA would not approve their use in humans before Senator Spector's target date.

Permalink to Comment

10. NoFreeLunchMD on August 24, 2005 12:49 PM writes...

Thanks Derek. You've said it better than I could. I hate it when people claim that "A cure to cancer exists, but is being hidden by the drug companies." On top of the fact that people will keep getting cancer, so the drug companies could easily make a fortune with such a cure, I also point out two other issues:

1) THERE IS NO SUCH DISEASE AS "CANCER." But your "fever" analogy is the best one I've heard.

2) THERE IS ALREADY A CURE FOR CANCER. Breast cancer, when caught early, can be cured. I've done it myself (well, I was a medical student first-assisting on the lumpectomy). Thyroid cancer is almost universally curable with radio-iodine therapy. And Lance Armstrong, while not yet "cured," may very well be if he crosses the mythical 5-year threshold.

I get irritated at breat cancer advocates who advocate "fighting for a cure," when the cure is early detection and excision. They want all cures to be as easy as a course of azithromycin. Not going to happen.

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
This All Too Open Office
Strangest Presentation You've Seen?
Worst Lecture of All, Or Greatest?
Alnylam Cuts Back Hard
Zelboraf: Treat One Cancer, Speed Up Another?
Dapagliflozin Goes Down (For the Last Time?)
Takeda Announces Cuts
The Research Works Act: One (Two!) Against and One For